Literature DB >> 25523105

The subpopulation of microglia expressing functional muscarinic acetylcholine receptors expands in stroke and Alzheimer's disease.

Maria Pannell1, Maria Almut Meier1, Frank Szulzewsky1, Vitali Matyash1, Matthias Endres2, Golo Kronenberg2, Vincent Prinz2, Sonia Waiczies3, Susanne A Wolf1, Helmut Kettenmann4.   

Abstract

Microglia undergo a process of activation in pathology which is controlled by many factors including neurotransmitters. We found that a subpopulation (11 %) of freshly isolated adult microglia respond to the muscarinic acetylcholine receptor agonist carbachol with a Ca(2+) increase and a subpopulation of similar size (16 %) was observed by FACS analysis using an antibody against the M3 receptor subtype. The carbachol-sensitive population increased in microglia/brain macrophages isolated from tissue of mouse models for stroke (60 %) and Alzheimer's disease (25 %), but not for glioma and multiple sclerosis. Microglia cultured from adult and neonatal brain contained a carbachol-sensitive subpopulation (8 and 9 %), which was increased by treatment with interferon-γ to around 60 %. This increase was sensitive to blockers of protein synthesis and correlated with an upregulation of the M3 receptor subtype and with an increased expression of MHC-I and MHC-II. Carbachol was a chemoattractant for microglia and decreased their phagocytic activity.

Entities:  

Keywords:  Alzheimer’s disease; Brain macrophages; Glioma; Microglia; Multiple sclerosis; Muscarinic acetylcholine receptors; Stroke

Mesh:

Substances:

Year:  2014        PMID: 25523105     DOI: 10.1007/s00429-014-0962-y

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  18 in total

Review 1.  Microglia emerge as central players in brain disease.

Authors:  Michael W Salter; Beth Stevens
Journal:  Nat Med       Date:  2017-09-08       Impact factor: 53.440

Review 2.  Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system.

Authors:  Mark A Barnes; Monica J Carson; Meera G Nair
Journal:  Cytokine       Date:  2015-02-18       Impact factor: 3.861

3.  The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.

Authors:  Nirmeen Elmadany; Felipe de Almeida Sassi; Stefan Wendt; Francesca Logiacco; Josien Visser; Verena Haage; Daniel Perez Hernandez; Philipp Mertins; Dolores Hambardzumyan; Susanne Wolf; Helmut Kettenmann; Marcus Semtner
Journal:  J Neurosci       Date:  2020-02-14       Impact factor: 6.167

4.  Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides.

Authors:  Maria Pannell; Dominika Labuz; Melih Ö Celik; Jacqueline Keye; Arvind Batra; Britta Siegmund; Halina Machelska
Journal:  J Neuroinflammation       Date:  2016-10-07       Impact factor: 8.322

5.  Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease.

Authors:  Kaitlyn K Thompson; Jillian C Nissen; Amanda Pretory; Stella E Tsirka
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

6.  Anti-inflammatory and antioxidant effects of muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus.

Authors:  Monica Frinchi; Domenico Nuzzo; Pietro Scaduto; Marta Di Carlo; Maria F Massenti; Natale Belluardo; Giuseppa Mudò
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

Review 7.  Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.

Authors:  Katarzyna Popiolek-Barczyk; Joanna Mika
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

8.  Evaluation of in vitro neuronal platforms as surrogates for in vivo whole brain systems.

Authors:  Anna M Belle; Heather A Enright; Ana Paula Sales; Kristen Kulp; Joanne Osburn; Edward A Kuhn; Nicholas O Fischer; Elizabeth K Wheeler
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

Review 9.  Interaction of Microglia and Astrocytes in the Neurovascular Unit.

Authors:  Li-Rong Liu; Jia-Chen Liu; Jin-Shuang Bao; Qin-Qin Bai; Gai-Qing Wang
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 10.  Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.

Authors:  Md Ezazul Haque; In-Su Kim; Md Jakaria; Mahbuba Akther; Dong-Kug Choi
Journal:  Front Cell Neurosci       Date:  2018-08-21       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.